License Agreements in the Pharmaceuticals Industry

1,226 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (2)
ACELRX PHARMACEUTICALS INC (2)
Acer Therapeutics Inc. (9)
Aclaris Therapeutics, Inc. (3)
ACURA PHARMACEUTICALS, INC (6)
Adamis Pharmaceuticals Corp (12)
ADIAL PHARMACEUTICALS, INC. (8)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (2)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (4)
ALIMERA SCIENCES INC (1)
ALSERES PHARMACEUTICALS INC (9)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (2)
ANGIOTECH PHARMACEUTICALS INC (8)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (1)
Apimeds Pharmaceuticals US, Inc. (1)
APRICUS BIOSCIENCES, INC. (8)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
Arog Pharmaceuticals, Inc. (3)
ARTELO BIOSCIENCES, INC. (10)
Artemis Therapeutics, Inc. (2)
ARVINAS, INC. (6)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (5)
Astex Pharmaceuticals, Inc (5)
ATAI Life Sciences B.V. (3)
Atea Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (17)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (2)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (9)
Bakhu Holdings, Corp. (5)
BARR PHARMACEUTICALS INC (2)
Baudax Bio, Inc. (6)
Bausch Health Companies Inc. (1)
BENTLEY PHARMACEUTICALS INC (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (6)
Biohaven Ltd. (3)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (5)
BRADLEY PHARMACEUTICALS INC (1)
Braeburn Pharmaceuticals, Inc. (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (1)
Cancer Prevention Pharmaceuticals, Inc. (4)
Cannabics Pharmaceuticals Inc. (3)
CANNAPOWDER, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
Cara Therapeutics, Inc. (9)
CASSAVA SCIENCES INC (5)
CELGENE CORP (1)
Cerecor Inc. (11)
Charlotte's Web Holdings, Inc. (7)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (11)
Clearside Biomedical, Inc. (15)
CNS Pharmaceuticals, Inc. (2)
Cocrystal Pharma, Inc. (6)
COLLEGIUM PHARMACEUTICAL, INC (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (3)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (4)
COSMO VENTURES INC (7)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (10)
CUMBERLAND PHARMACEUTICALS INC (2)
CymaBay Therapeutics, Inc. (4)
Dermata Therapeutics, Inc. (2)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (25)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (6)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (20)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (17)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (10)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (3)
Evofem Biosciences, Inc. (3)
Evolus, Inc. (8)
EYEGATE PHARMACEUTICALS INC (9)
EYENOVIA, INC. (7)
EyePoint Pharmaceuticals, Inc. (4)
EYETECH PHARMACEUTICALS INC (3)
Fulcrum Therapeutics, Inc. (3)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (4)
Harmony Biosciences Holdings, Inc. (3)
HARROW HEALTH, INC. (10)
Horizon Pharma plc (21)
Hoth Therapeutics, Inc. (7)
IDENIX PHARMACEUTICALS INC (7)
Ikena Oncology, Inc. (2)
IMAGING3 INC (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
Innovive Pharmaceuticals, Inc. (3)
INSPIRE PHARMACEUTICALS INC (7)
IntelGenx Technologies Corp. (1)
Intra-Cellular Therapies, Inc. (4)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (9)
Jazz Pharmaceuticals plc (14)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (13)
Kala Pharmaceuticals, Inc. (5)
Kannalife Inc (2)
KING PHARMACEUTICALS INC (5)
KOS PHARMACEUTICALS INC (2)
Lannett Company, Inc. (3)
Level Brands, Inc. (6)
Lexaria Bioscience Corp. (16)
Lipocine Inc. (3)
Liquidia Corp (5)
Longboard Pharmaceuticals, Inc. (3)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (3)
Lumena Pharmaceuticals, Inc. (3)
MAP Pharmaceuticals, Inc. (4)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (4)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (3)
MJ Holdings, Inc. (2)
Molecular Insight Pharmaceuticals, Inc. (13)
MYnd Analytics, Inc. (1)
Nabriva Therapeutics plc (3)
NEKTAR THERAPEUTICS (4)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (3)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (2)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (15)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (16)
OCULAR THERAPEUTIX, INC (5)
Odonate Therapeutics, Inc. (1)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (13)
Onconova Therapeutics, Inc. (3)
ONYX PHARMACEUTICALS INC (1)
OPIANT PHARMACEUTICALS, INC. (11)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (2)
Organon & Co. (1)
OSCIENT PHARMACEUTICALS CORP (8)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (1)
OTONOMY, INC. (2)
Panacea Acquisition Corp (4)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (19)
PaxMedica, Inc. (4)
PEAK PHARMACEUTICALS, INC. (1)
Petros Pharmaceuticals, Inc. (3)
Phathom Pharmaceuticals, Inc. (3)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (2)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (2)
PREDIX PHARMACEUTICALS HOLDINGS INC (2)
PRESTWICK PHARMACEUTICALS INC (2)
Processa Pharmaceuticals, Inc. (10)
ProPhase Labs, Inc. (2)
PROTEO INC (2)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (6)
QUARK PHARMACEUTICALS INC (14)
QUATRX PHARMACEUTICALS CO (6)
QUESTCOR PHARMACEUTICALS INC (1)
Quoin Pharmaceuticals, Ltd. (1)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (6)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (22)
Recro Pharma, Inc. (8)
Reliant Pharmaceuticals, Inc. (10)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (10)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (6)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (4)
SALIX PHARMACEUTICALS LTD (13)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (7)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (11)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
Somanta Pharmaceuticals Inc. (1)
Sonoma Pharmaceuticals, Inc. (9)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (4)
Supernus Pharmaceuticals, Inc. (8)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (5)
TAURIGA SCIENCES, INC. (4)
Telomir Pharmaceuticals, Inc. (2)
Terns Pharmaceuticals, Inc. (3)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (2)
Textmunication Holdings, Inc. (1)
TFF Pharmaceuticals, Inc. (3)
The Medicines Company (1)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (3)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (4)
Trevi Therapeutics, Inc. (4)
Tribute Pharmaceuticals Canada Inc. (3)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (5)
Urovant Sciences Ltd. (3)
Valera Pharmaceuticals Inc (4)
Vallon Pharmaceuticals, Inc. (1)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (6)
Virpax Pharmaceuticals, Inc. (6)
Vitality Biopharma, Inc. (3)
VIVUS INC (7)
Wave Life Sciences Ltd. (3)
WEED, INC. (1)
Zoetis (5)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (5)

Recent Contracts

Exclusive License Agreement by and between the StemMed, Ltd. and Baylor College of Medicine, dated June 19, 2015, subject to Notice of Assignment from Stem Med Limited Partnership... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
Exclusive License Agreement by and between the StemMed, Ltd. (f/k/a Stem Med Limited Partnership) and Baylor College of Medicine, dated July 16, 2012, as amended April 26, 2015,... (Cara Therapeutics, Inc., Filed With SEC on December 18, 2024)
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018 (DURECT CORP, Filed With SEC on November 14, 2024)
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015 (DURECT CORP, Filed With SEC on November 14, 2024)
First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on November 13, 2024)
Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on November 13, 2024)
First Amendment to the License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of September 22, 2023 (Roivant Sciences Ltd., Filed With SEC on November 12, 2024)
License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of July 27, 2023 (Roivant Sciences Ltd., Filed With SEC on November 12, 2024)
Rest of World License Term Sheet, dated October 8, 2024, between Oramed Pharmaceuticals Inc., Scilex Holding Company and the other parties signatories thereto (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
Patent License Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated October 12, 2021 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
LICENSE AGREEMENT (Context Therapeutics Inc., Filed With SEC on September 23, 2024)
Intellectual Property Cross License Agreement, dated as of May 28, 2024, by and between Pulmatrix, Inc. and MannKind Corporation (Pulmatrix, Inc., Filed With SEC on August 13, 2024)
First Amendment to License Agreement, by and among the Registrant and BioCryst Pharmaceuticals, Inc., dated as of May 20, 2024 (Clearside Biomedical, Inc., Filed With SEC on August 12, 2024)
Exclusive License Agreement between CNS Pharmaceuticals, Inc. and Cortice Biosciences, Inc (CNS Pharmaceuticals, Inc., Filed With SEC on July 30, 2024)
License Agreement, by and between the Company and Pharma 1 Drug Store, L.L.C (Evofem Biosciences, Inc., Filed With SEC on July 23, 2024)
License and Commercialization Agreement between Nippon Kayaku Co., Ltd. and AnHeart Therapeutics Inc, dated October 27, 2023 (Panacea Acquisition Corp, Filed With SEC on June 20, 2024)
License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated September 7, 2020 (Panacea Acquisition Corp, Filed With SEC on May 14, 2024)
First Amendment to License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therpaeutics Inc., dated August 17, 2020 (Panacea Acquisition Corp, Filed With SEC on May 14, 2024)
License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated December 7, 2018 (Panacea Acquisition Corp, Filed With SEC on May 14, 2024)
First Amendment to Amended and Restated License Agreement, dated March 16, 2024, by and between Napo Pharmaceuticals, Inc. and Nano Therapeutics S.p.A (Jaguar Health, Inc., Filed With SEC on May 14, 2024)
First Amendment to License Agreement, dated (Cerecor Inc., Filed With SEC on May 13, 2024)
License Agreement by, dated November 25, 2019, by and between Flame Biosciences LLC and Eli Lilly and Company (Cerecor Inc., Filed With SEC on May 13, 2024)
Amended and Restated License Agreement, dated January 27, 2012, between the Registrant and Incept LLC (OCULAR THERAPEUTIX, INC, Filed With SEC on May 7, 2024)
Amendment No. 2 to License and Commercialization Agreement, dated July 28, 2017, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC (Harmony Biosciences Holdings, Inc., Filed With SEC on April 30, 2024)
Amendment No. 1 to License and Commercialization Agreement, dated July 31, 2022, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC (Harmony Biosciences Holdings, Inc., Filed With SEC on April 30, 2024)
Amended and Restated Intellectual Property License Agreement with Premier Anti-Aging Co., Ltd. dated March 15, 2024 (Lexaria Bioscience Corp., Filed With SEC on April 9, 2024)
License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Zomedica Pharmaceuticals Corp., Filed With SEC on April 1, 2024)
Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010 (OMEROS CORP, Filed With SEC on April 1, 2024)
Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between... (SCYNEXIS INC, Filed With SEC on March 28, 2024)
Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on March 27, 2024)
License Agreement Dated June 15, 2023 by and between Star Brands and Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 27, 2024)
Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A (HARROW HEALTH, INC., Filed With SEC on March 19, 2024)
License Agreement, effective as of March20, 2024, by and between cbdMD, Inc. and HSKL, Inc (Level Brands, Inc., Filed With SEC on March 18, 2024)
License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on March 13, 2024)
Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V. and Symatese Aesthetics S.A.S (Evolus, Inc., Filed With SEC on March 7, 2024)
Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant (Evolus, Inc., Filed With SEC on March 7, 2024)